Barts Haemato-Oncology ResearchTissue Bank

• Research type

  Research Tissue Bank

• IRAS ID

  283103

• Research summary

  Barts Haemato-Oncology Tissue Bank

• REC name

  East of England - Cambridge Central Research Ethics Committee

• REC reference

  21/EE/0123

• Date of REC Opinion

  11 Jun 2021

• REC opinion

  Further Information Favourable Opinion

• Data collection arrangements

  We intend to create a collection of haematological cancer and other malignant and benign control tissues including blood, bone marrow, lymph node biopsies, leucopheresis samples from primary metastatic sites as well as blood donations from healthy volunteers. This collection of tissue will be used for research into improving the outlook for people with haematological cancers. Suitable patients will be approached by trained members of their healthcare team or trained members of the Haemato-Oncology Tissue Bank team to discuss and gain informed consent. These same members will be responsible for the collection and storage of tissues and routine anonymised clinical data.

• Research programme

  The human tissue is primarily collected from patients treated at Barts NHS Trust sites and aims to support research programmes at the Barts Cancer Institute, external academics and commercial collaborators who work in the field of haematological malignancy.

• Storage license

  12199

• RTBTitle

  Barts Haemato-Oncology Tissue Bank

• Establishment organisation

  Queen Mary University of London - Barts Cancer Institute

• Establishment organisation address

  John Vane Science Centre

  Charterhouse Square

  London

  EC1M 6BQ